Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My average is .045.
My average is $3.34.
My average is .19.
My average is .32.
Who's selling when OVIT is allegedly going to do a reverse merger, shell into a new company that wants to incorporate and go public for a cheaper price?
My average is $36 per share. That's what I get for not following my gut and getting in too high. Hooray for me! I did not trust that article written by that female "analyst-journalist" saying that she thought ACAD would be bought out soon, I but too high regardless of my disbelief and that was followed by fake news CNN writing a fake article, which cut ACAD's share price in half. Oh how I hate fake news-lying CNN!
Are you gone now, ALL-IN888? If so, it was nice having your around, day trading for a couple of days. I'm sure many miss your unique style of pumping and posting, posting and pumping.
Well, I hope you don't end up being short lived.
That sounds great JTaylor, those are the only known catalysts that I'm aware of at the moment. Let's hope after those are achieved, or as they're being achieved that more, good catalysts are created.
Bate, those are two good product ideas. In the meantime, you might want to consider using this;
Melatonin MZS Sleep Disorder & Reversal of Macular Degeneration 60 Count
https://www.amazon.com/Melatonin-Disorder-Reversal-Macular-Degeneration/dp/B00F6EQ7SY/ref=sr_1_fkmr0_1_s_it?s=hpc&ie=UTF8&qid=1532108233&sr=1-1-fkmr0&keywords=innovus+pharmaceutical+sleep
Apparently, it is sold by Innovus, with some sort of a marketing agreement, similar to the Can-C product agreement.
If you go to Amazon and search; Innovus pharmaceutical sleep, it will appear.
I use the MZS sleep product several nights a week and it makes me fall asleep faster and sleep deeper.
Ok cool, one other thing, after I've purchased and used several different Innovus products and had positive results with them, I posted that feed back online, with Amazon/Beyond Human.
Lol, Bate! I'd be totally lost!
Cheers to INNV's success!
A couple of other things. I have contributed to the success of INNV, by buying their stock and whenever possible buying their products for myself and family.
Granted, it's not much of a contribution, but it does help in a positive way and I've also posted some marketing ideas, which again probably haven't helped much, but at least I'm trying.
INNV implemented one of my suggestions after I posted it, but I'm not trying to take credit for it, because, I'm sure they had it in the works, before I posted and also, it was a no-brainier idea.
I don't need an apology, but if I said something proven to be wrong and nasty like you did, I would apologize.
Regardless, good luck to you and have a great weekend!
I give credit to Dr.Damaj and INNV for this success.
There is a difference between being negative and being realistic.
There are plenty of people on here, much more negative than me and yet you chose to call me out...
If your main thing is post Yippie and YeeHaw, then good for you.
I am conservative in my posts and I'm always aware of pros and cons to everything in life.
For the next foreseeable future INNV looks great.
Ya, support what you're invested in, if you have any condition, like allergies or something, buy Fluticare and any of the other Innovus producst.
Huh? Where did that come from? I like what INNV is doing. I am long and always have been long.
Understood and ya I'd like to see all of those products on store shelves. I think the Vesele bottle needs an upgrade, it's not eye catching.
It could be good to sell all Innovus products at CVS and as we already do online, but I know not everything can or should happen at once.
Good luck.
It's great news about the pilot program with CVS, but why start with Androfertti? I would have started with Fluticare, which in my opinion has a higher probability of success.
I agree Bate, INNV "could" make up for the OVIT debacle :)
There will be an increase in costs, or SG&A, which is to be expected with a growing company.
I wonder if INNV will also end up selling on Ali Baba's website?
I hope we get the original FDA, ANDA approval for Fluticare now.
I hope we don't do a premature r/s. I don't want an r/s at all.
I see that CNN upgraded their price target for INNV, but also keep in mind that CNN is being sued, for doing a hit piece on ACAD/Nuplazid, which was proven to be false, which recently caused the share price to be cut in half. I was screwed over by that, but I'm still long on ACAD.
Just trying to keep my emotions in check...
Thanks and have a great day!
It's not just a matter of the PPS going up, but it remaining up, unless you're short. INNV can go as high as you make it go, provided that you buy lots of shares and also by some of their products. Please reply and let us know, after you've purchased 1,000,000,000 shares.
Thank you.
Huge volume today and with a high of .1839
I've been quietly reading all of this good news and I like it. No matter what, I was long anyway.
I'm sorry, no it's my bad. I misunderstood the article completely, I thought ACAD was being sued and not CNN. I've never sued anyone, but I hate CNN and the deserve to be sued for a variety of reasons. I will have to look at the documentation. We might receive a letter in the mail about this.
What are you talking about? I thought you agreed ACAD shouldn't be sued and that CNN should be sued instead, for writing the fake news hot piece, that dropped the share price in half.
Now you're asking me to help you proceed on suing ACAD?
No, I'm not helping you. Go sue your own hinder!
ACADIA Investigated by Block & Leviton LLP For Violations of Federal Securities Laws;
(Leviton LLP should be investigating the fake hit piece by CNN and suing CNN instead...)
Jul 18, 2018 11:55:00 (ET)
BOSTON, July 18, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether ACADIA Pharmaceuticals, Inc. ("ACADIA" or the "Company") (NASDAQ: ACAD) and certain of its officers and directors violated federal securities laws.
On April 9, 2018, CNN reported that ACADIA's Nuplazid treatment may have played a role in the death of ill and elderly patients. On this news, shares in the Company plunged 23%. Subsequently, on July 9, 2018, the Southern Investigative Reporting Foundation released a report alleging that the Company's approach to government approval is best described as "loophole-centric." Following this report, the Company's shares dropped more than 6%.
If you purchased or otherwise acquired ACADIA securities and have questions about your legal rights, or possess information relevant to this investigation, you are encouraged to contact attorney John DeFelice at (888) 868-2385, by email at john@blockesq.com or by visiting http://shareholder.law/acadia.
Block & Leviton LLP was recently ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nations' largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.
This notice may constitute attorney advertising.
CONTACT:
BLOCK & LEVITON LLP
John DeFelice
(617) 398-5600 phone
155 Federal Street, Suite 400
Boston, MA 02110
john@blockesq.com
View original content:http://www.prnewswire.com/news-releases/acadia-pharmaceuticals-inc-acad-investigated-by-block--leviton-llp-for-violations-of-federal-securities-laws-300683034.html
SOURCE Block & Leviton LLP
/Web site: http://www.blockesq.com
(END) Dow Jones Newswires
July 18, 2018 11:55 ET (15:55 GMT)
We have a chance today at 1 million in volume, before the market closes.
I'm impressed, that's great news about Q2. I just want to be cautiously optimistic, that SG&A won't be high and that profitability will be attainable...
I also hope, that since guidance was raised to 22m for 2018, that we don't miss it by being at 20m, which would still be outstanding, but but sometimes the market reacts stupidly...
I just hope we are profitable and not spending 1.25 or 1.50 to make 1.00.
Good luck to us all.
Hi, what stock other than INNV are you guys talking about? Just wondered what other stock you thought would do well, thank you.
Nice gain and good volume today.
Re: Jocynda; There aren't any patents pending as in new products that I'm aware of...
However, some of their current products are still ramping up to full potential, especially due to the expanded sales agreement with Amazon, outside of the USA.
For the past 4 years, there has been an original, Fluticare, ANDA pending approval with the FDA. Approval would mean a higher profit margin and the expanded worldwide sales of Fluticare.
As it stands now, Innovus sells Fluticare, but only in the USA, for less of a profit due to an agreement with a secondary Fluticare manufacture, as compared to having the original Fluticare ANDA, FDA approved.
I could see a potential where Innovus would seek to sell generic, OTC Viagra and combine it with Vesele, but I don't have any news of that, I just think it would be a good combination.
There are probably some things in the works, that we're not aware of, that way may learn of, during the August, Q2, 2018 conference call.
In my opinion, it's a good time for investors to open a position on Innovus now, when it's near a historic low of .11, because expansion and growth appears to be the trend.
Sounds good and thanks for the info.
It was nice to see INNV hold onto a gain @ .11 today. I'm in for the long haul, so I'm aware it goes up and down.
Wow, it's dropping and dropping! It could be time to buy more! Hopefully, this one trick pony, Nuplazid/Pimavanserin will have multiple indications and by a MAJOR BLOCKBUSTER!
Re: Jtalor68; Ya, I agree and it seems many people on here are paranoid. I understand getting discouraged once in a while, but geeze...
I think a good strategy is to at least hold until the end of the year and perhaps buy more, if the Q's are good and the share price stays low.
Holding and selling at a break even point is not good, but selling at a high and before the r/s would probably be good and then maybe buy back in, after the shorters drop it down further after the r/s.
Hopefully, the r/s comes at the right time, not prematurely and isn't too drastic of an r/s.
Good luck!
Not to be conspiratorial, but I would think that the feminized/gynocentric, pussified FDA would want to approved the PTB, because it helps women...
It would obviously be major for LPCN, if the 3 times per day Tlando pill got approved sometime in 2019 (I wish it could be approved in 2018.)
It would be major, if the PTB pill got approval in 2019.
It would also be major, if the once per day TLando pill got approval in 2019 as well.
I don't have any fantasies of becoming rich, but LPCN could become a valuable stock, if things start going positively for them.
Thanks grizz, if PTB fails phase III, it will really suck for us LPCN investors, especially due to what happened and is happening with TLando.
Re: Grizzly2314; It's been a couple of weeks, any luck yet? Were you able to determine if the preterm birth pill was going under FDA review this year, before Tlando gets resubmitted again, next year in 2019, after the new blood pressure study, etc?
Re: ShawnP123; Ok, it sounds like you got to the bottom line, regarding the low share price, it's mainly due to a lack of trust.
Hopefully, Q2,3 and 4 will be good, which could go a long way in restoring trust and credibility.
Re: Drugdoctor; It's true that several times after Qs are reported, Innovus has bounced up to .20. However, even after the 1st, record Q this year, Innovus didn't bounce up to .20, so there aren't any guarantees.
It's kind of amazing that the share price is below .11 now, after the good news of expanding the Amazon sales overseas.
It's a little hard to believe that anyone would be selling at these low prices, therefore, it's probably market manipulators.
It would seem like now is the time to buy. I am waiting until I have more capital, to buy more. (I recently spent a lot on fishing gear.)
I guess this gives a little more credibility, to actual profits being one of the few things that will move the price up.
With the expanded Amazon, over seas sales, it could help the 3rd Q and also the 4th Q, which is great, because Q4 has typically been low, due to Innovus stating that ad space in newspapers is harder to get around the holidays.
Good luck to all, including Drugdoctor.